NVR RIC (Kisqali 200 mg)

Generic Name: ribociclib

Pill with imprint NVR RIC is Purple, Round and has been identified as Kisqali 200 mg. It is supplied by Novartis Pharmaceuticals Corporation.

Kisqali is used in the treatment of breast cancer, metastatic; breast cancer and belongs to the drug class CDK 4/6 inhibitors. Kisqali 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NVR RIC

Kisqali

Generic Name:

ribociclib

Imprint:

NVR RIC

Strength:

200 mg

Color:

Purple

Shape:

Round

Availability:

Prescription only

Drug Class:

CDK 4/6 inhibitors

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Novartis Pharmaceuticals Corporation

National Drug Code (NDC):

00078-0874

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer